Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07279129 · ClinicalTrials.gov registry record · Phase 1
Decision Support Tool to Integrate PrEP Into Emergency Departments
A Phase 1 study, sponsored by George Washington University.
- Not yet
- Registry status
- Phase 1
- Development phase
- 120
- Enrollment target
NCT07279129: Clinical Trial Phase 1 study, sponsored by George Washington University.
NCT07279129 is a Phase 1 study that has not yet begun recruiting, run by George Washington University. The registered enrollment target is 120 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (100% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07279129, a Phase 1 study, has not yet begun recruiting, sponsored by George Washington University.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 120 participants
- Enrollment target
Study Summary
This project will explore the development of a personalized decision support tool to assist with pre-exposure prophylaxis (PrEP) initiation and persistence among patients identified in the emergency department (ED) and urgent care settings as PrEP eligible. First, the investigators will use a sequence of validated implementation science methodologies to develop and validate a decision support tool designed to optimize PrEP persistence by strengthening self-efficacy by addressing the multifaceted medical and social needs of the individual patient. The investigators will then test the preliminary effectiveness of this tool through a pilot stepped wedge implementation trial in two EDs and an urgent care in Baltimore, MD and Washington, DC among 120 PrEP eligible patients to determine PrEP initiation, linkage to care, persistence, and adherence rates.
Primary Outcome
PrEP persistence defined as self-report of taking PrEP in the past 4 months and having any TFV-DP detected in DBS
Interventions
- BEHAVIORAL Decision support tool
- BEHAVIORAL PrEP Delivery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2027-01-15 |
| Est. Completion | 2028-09-09 |
| Phase | Phase 1 |
What is known before NCT07279129 opens enrollment
NCT07279129 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (100% higher).
The record links to 0 conditions, and to 2 interventions - of which Decision support tool is the first listed.
NCT07279129 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07279129 about?
NCT07279129 is a clinical study titled "Decision Support Tool to Integrate PrEP Into Emergency Departments". This project will explore the development of a personalized decision support tool to assist with pre-exposure prophylaxis (PrEP) initiation and persistence among patients identified in the emergency department (ED) and urgent care settings as PrEP eligible. First, the investigators will use a sequen...
What is the current status of trial NCT07279129?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 120 participants. The study started on 2027-01-15. Estimated completion is 2028-09-09.
What interventions are being tested in trial NCT07279129?
The interventions under investigation include: Decision support tool (BEHAVIORAL), PrEP Delivery (BEHAVIORAL).
Who is sponsoring clinical trial NCT07279129?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07279129's enrollment target sits among peer trials
120 479th of 2000 higher than 1,503 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI